Concordance of Fingerstick and Venipuncture Sampling for Fertility Hormones
- PMID: 30633131
- DOI: 10.1097/AOG.0000000000003066
Concordance of Fingerstick and Venipuncture Sampling for Fertility Hormones
Abstract
Background: Minimally invasive fingerstick sampling allows testing of reproductive hormone levels at home, providing women with increased access to tests that can screen for conditions such as polycystic ovarian syndrome, primary ovarian insufficiency, and pituitary and thyroid dysfunction.
Method: We present a measurement procedure comparison study of matched venipuncture and fingerstick samples from 130 women aged 18-40 years, tested on menstrual cycle day 3. Samples were measured for anti-müllerian hormone, estradiol (E2), follicle-stimulating hormone (FSH), luteinizing hormone (LH), prolactin (PRL), testosterone, thyroid-stimulating hormone (TSH), and free thyroxine (T4) levels. Samples were tested using U.S. Food and Drug Administration-cleared immunoassays, with a modified reconstitution step for fingerstick samples.
Experience: Venipuncture and fingerstick hormone values were concordant and linear across all assay ranges. There was no evidence of systematic bias across the assay ranges, and bias measures were below recommended guidelines. The correlation between venipuncture and fingerstick was between 0.99 and 1.0 for each hormone. Each assay displayed a high degree of precision (less than 13% coefficient of variation) and a high level of accuracy (average recovery equaled 95.5-102.3%).
Conclusion: Venipuncture and fingerstick samples can be used interchangeably to measure anti-müllerian hormone, E2, FSH, LH, PRL, testosterone, TSH, and free T4 levels. Fingerstick sampling provides doctors and women more convenient testing options.
Funding source: The study was sponsored by Modern Fertility.
Comment in
-
Concordance of Fingerstick and Venipuncture Sampling for Fertility Hormones.Obstet Gynecol. 2019 Aug;134(2):418. doi: 10.1097/AOG.0000000000003344. Obstet Gynecol. 2019. PMID: 31348210 No abstract available.
-
In Reply.Obstet Gynecol. 2019 Aug;134(2):418-420. doi: 10.1097/AOG.0000000000003350. Obstet Gynecol. 2019. PMID: 31348211 No abstract available.
References
-
- McDade TW, Woodruff TK, Huang YY, Funk WE, Prewitt M, Kondapalli L, et al. Quantification of anti-Müllerian hormone (AMH) in dried blood spots: validation of a minimally invasive method for assessing ovarian reserve. Hum Reprod 2012;27:2503–8.
-
- McDade TW, Williams S, Snodgrass JJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography 2007;44:899–925.
-
- Clinical and Laboratory Standards Institute. Measurement procedure comparison and bias estimation using patient samples; approved guideline. CLSI document EP09c. 3rd ed. Wayne (PA): Clinical and Laboratory Standards Institute; 2018.
-
- Deming WE. Statistical adjustment of data. Oxford, England: Wiley, 1943.
-
- Westgard QC. Desirable specifications for total error, imprecision, and bias, derived from intra- and inter-individual biologic variation. Available at: https://www.westgard.com/biodatabase1.htm. Retrieved January 19, 2018.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical